Aventus Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.9K Hold
230
0.04% 54
2026
Q1
$50K Hold
230
0.04% 54
2025
Q4
$52.6K Hold
230
0.04% 53
2025
Q3
$53.3K Hold
230
0.05% 51
2025
Q2
$42.7K Buy
+230
New +$42.7K 0.04% 53

Other funds holding ABBV

Aventus Investment Advisors's ABBV Position: Q2 2026 in Review

Aventus Investment Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 230 shares worth $57.9K. The position accounts for 0.04% of the portfolio, ranked #54.

Aventus Investment Advisors first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 1,570 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aventus Investment Advisors held 230 shares of AbbVie worth $57.9K as of Q2 2026.
  • Aventus Investment Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.04% of Aventus Investment Advisors's portfolio in Q2 2026, its #54 holding.
  • Aventus Investment Advisors first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 1,570 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aventus Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.